Free Trial

SurgePays (SURG) Competitors

SurgePays logo
$3.16 +0.12 (+3.95%)
Closing price 04:00 PM Eastern
Extended Trading
$3.15 -0.01 (-0.44%)
As of 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SURG vs. SKIN, NYXH, DRTS, ELMD, RCEL, CATX, INGN, LAKE, BWAY, and SGHT

Should you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Beauty Health (SKIN), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Electromed (ELMD), AVITA Medical (RCEL), Perspective Therapeutics (CATX), Inogen (INGN), Lakeland Industries (LAKE), BrainsWay (BWAY), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

SurgePays vs.

Beauty Health (NASDAQ:SKIN) and SurgePays (NASDAQ:SURG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, Beauty Health had 11 more articles in the media than SurgePays. MarketBeat recorded 17 mentions for Beauty Health and 6 mentions for SurgePays. Beauty Health's average media sentiment score of 1.09 beat SurgePays' score of 0.19 indicating that Beauty Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beauty Health
12 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SurgePays
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Beauty Health has a net margin of -8.11% compared to SurgePays' net margin of -27.39%. Beauty Health's return on equity of -44.83% beat SurgePays' return on equity.

Company Net Margins Return on Equity Return on Assets
Beauty Health-8.11% -44.83% -3.54%
SurgePays -27.39%-55.63%-43.61%

Beauty Health presently has a consensus price target of $1.42, indicating a potential downside of 18.11%. SurgePays has a consensus price target of $8.75, indicating a potential upside of 176.90%. Given SurgePays' stronger consensus rating and higher probable upside, analysts plainly believe SurgePays is more favorable than Beauty Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
SurgePays
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by insiders. Comparatively, 30.5% of SurgePays shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SurgePays has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beauty Health$322.47M0.67-$100.12M-$0.41-4.22
SurgePays$40.03M1.61$20.62M-$2.79-1.13

Beauty Health has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500.

SurgePays received 131 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 68.95% of users gave SurgePays an outperform vote while only 44.94% of users gave Beauty Health an outperform vote.

CompanyUnderperformOutperform
Beauty HealthOutperform Votes
40
44.94%
Underperform Votes
49
55.06%
SurgePaysOutperform Votes
171
68.95%
Underperform Votes
77
31.05%

Summary

Beauty Health beats SurgePays on 10 of the 18 factors compared between the two stocks.

Get SurgePays News Delivered to You Automatically

Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SURG vs. The Competition

MetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ Exchange
Market Cap$64.50M$24.46B$25.07B$8.39B
Dividend YieldN/A13.18%2.89%4.11%
P/E Ratio-2.8015.2544.3819.71
Price / Sales1.613.472,068.55120.55
Price / Cash1.099.0234.7834.62
Price / Book1.882.816.704.50
Net Income$20.62M$1.01B$739.31M$248.22M
7 Day Performance19.70%0.03%-0.32%0.56%
1 Month Performance17.47%4.88%13.46%13.17%
1 Year Performance-21.00%9.74%52,670.39%7.30%

SurgePays Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SURG
SurgePays
2.8364 of 5 stars
$3.16
+3.9%
$8.75
+176.9%
-22.4%$64.50M$40.03M-2.8040Analyst Upgrade
SKIN
Beauty Health
0.3791 of 5 stars
$1.76
-5.9%
$2.45
+39.2%
-41.1%$220.43M$322.47M-4.191,030Positive News
High Trading Volume
NYXH
Nyxoah
2.9552 of 5 stars
$5.98
-5.1%
$14.50
+142.5%
-19.5%$203.68M$4.52M-3.20110Gap Up
DRTS
Alpha Tau Medical
2.0012 of 5 stars
$2.80
-5.1%
$8.00
+185.7%
+14.3%$197.07MN/A-6.5180Earnings Report
ELMD
Electromed
1.2123 of 5 stars
$22.44
+0.8%
$38.00
+69.3%
+24.4%$192.02M$59.63M29.92160Positive News
RCEL
AVITA Medical
1.3951 of 5 stars
$7.25
+4.0%
$17.25
+137.9%
-19.9%$191.65M$64.25M-3.03130High Trading Volume
CATX
Perspective Therapeutics
3.4274 of 5 stars
$2.51
+6.8%
$12.75
+408.0%
-84.4%$185.87M$1.43M0.0070News Coverage
Analyst Revision
INGN
Inogen
4.1349 of 5 stars
$6.30
+1.0%
$7.00
+11.1%
-30.8%$169.39M$335.71M-2.801,030Analyst Upgrade
Gap Up
LAKE
Lakeland Industries
4.726 of 5 stars
$17.76
+4.1%
$27.00
+52.0%
+6.5%$168.92M$167.21M-197.331,800News Coverage
Positive News
Gap Up
BWAY
BrainsWay
3.7197 of 5 stars
$8.83
+1.4%
$14.25
+61.4%
+91.5%$166.64M$41.02M88.31120
SGHT
Sight Sciences
3.4047 of 5 stars
$3.21
+4.2%
$3.92
+22.0%
-40.7%$165.94M$79.87M-3.15210Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:SURG) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners